DYN · Dyne Therapeutics, Inc.

$26.10 +0.12 (+0.46%) At close · Aug 21

Market Cap

$4.87B

186.75M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-07-29	2026-06-30
8-K	2026-07-29	—
8-K	2026-07-22	2026-07-21
8-K	2026-07-20	—
8-K	2026-06-22	—
8-K	2026-06-17	2026-06-16
8-K	2026-06-08	2026-06-05
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-06-03	—
10-Q	2026-05-11	2026-03-31
8-K	2026-05-11	—
DEF 14A	2026-04-23	2026-04-22
10-K	2026-03-02	2025-12-31
8-K	2026-03-02	—
8-K	2026-01-12	—
8-K	2025-12-23	2025-12-22
8-K	2025-12-10	2025-12-09
8-K	2025-12-08	—
8-K	2025-12-08	—
10-Q	2025-11-05	2025-09-30
8-K	2025-11-05	—
8-K	2025-10-02	2025-10-01
8-K	2025-08-04	—
10-Q	2025-07-28	2025-06-30
8-K	2025-07-28	—
8-K	2025-07-01	2025-06-30
8-K	2025-06-30	2025-06-27
8-K	2025-06-17	—
8-K	2025-06-05	2025-05-30
10-Q	2025-05-08	2025-03-31
8-K	2025-05-08	—
DEF 14A	2025-04-15	2025-05-30
8-K	2025-03-20	2025-03-17
10-K	2025-02-27	2024-12-31
8-K	2025-02-27	—
8-K	2025-01-10	—
8-K	2024-11-12	—
10-Q	2024-11-12	2024-09-30
8-K	2024-11-12	—
8-K	2024-09-03	2024-08-31
10-Q	2024-08-12	2024-06-30
8-K	2024-08-12	—
8-K	2024-05-24	2024-05-22
8-K	2024-05-22	2024-05-21
8-K	2024-05-20	—
10-Q	2024-05-02	2024-03-31
8-K	2024-05-02	—
DEF 14A	2024-04-05	2024-05-22
8-K	2024-03-25	2024-03-21
8-K	2024-03-05	—

Showing 1–50 of 95 filings

Key facts CIK 1818794 CUSIP 26818M108 13F (30d) 231 filings 225 filers Visit website Investor relations